- MRKR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Marker Therapeutics (MRKR) 8-K12 Jun 23Marker Therapeutics Announces First Lymphoma Patient Treated with MT-601 in Phase 1 Clinical TrialFinancial data
Company Profile